WallStSmart

Lichen China Limited Class A Ordinary Shares (LICN)vsRB Global Inc. (RBA)

VS
⚡

Smart Verdict

WallStSmart Research — data-driven comparison

RB Global Inc. generates 23522% more annual revenue ($4.85B vs $20.52M). RBA leads profitability with a 10.0% profit margin vs -117.7%. LICN trades at a lower P/E of 0.0x. RBA earns a higher WallStSmart Score of 68/100 (B-).

LICN

Avoid

29

out of 100

Grade: F

Growth: 2.0Profit: 2.0Value: 6.7Quality: 8.5
Piotroski: 2/9Altman Z: 9.00

RBA

Strong Buy

68

out of 100

Grade: B-

Growth: 8.7Profit: 6.5Value: 7.3Quality: 5.5
Piotroski: 4/9Altman Z: 1.35
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

Intrinsic value data unavailable for LICN.

RBAUndervalued (+62.7%)

Margin of Safety

+62.7%

Fair Value

$305.11

Current Price

$84.41

$220.70 discount

UndervaluedFair: $305.11Overvalued

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

LICN4 strengths · Avg: 10.0/10
P/E RatioValuation
0.0x10/10

Attractively priced relative to earnings

Price/BookValuation
0.2x10/10

Reasonable price relative to book value

Debt/EquityHealth
0.0010/10

Conservative balance sheet, low leverage

Altman Z-ScoreHealth
9.0010/10

Safe zone — low bankruptcy risk

RBA3 strengths · Avg: 8.0/10
PEG RatioValuation
0.658/10

Growing faster than its price suggests

Price/BookValuation
2.8x8/10

Reasonable price relative to book value

EPS GrowthGrowth
34.0%8/10

Earnings expanding 34.0% YoY

Areas to Watch

LICN4 concerns · Avg: 2.5/10
Market CapQuality
$16.82M3/10

Smaller company, higher risk/reward

Piotroski F-ScoreQuality
2/93/10

Weak financial health signals

Return on EquityProfitability
-39.8%2/10

ROE of -39.8% — below average capital efficiency

Revenue GrowthGrowth
-28.0%2/10

Revenue declined 28.0%

RBA2 concerns · Avg: 3.0/10
P/E RatioValuation
36.3x4/10

Premium valuation, high expectations priced in

Altman Z-ScoreHealth
1.352/10

Distress zone — elevated risk

Comparative Analysis Report

WallStSmart Research

Bull Case : LICN

The strongest argument for LICN centers on P/E Ratio, Price/Book, Debt/Equity.

Bull Case : RBA

The strongest argument for RBA centers on PEG Ratio, Price/Book, EPS Growth. Revenue growth of 11.1% demonstrates continued momentum. PEG of 0.65 suggests the stock is reasonably priced for its growth.

Bear Case : LICN

The primary concerns for LICN are Market Cap, Piotroski F-Score, Return on Equity.

Bear Case : RBA

The primary concerns for RBA are P/E Ratio, Altman Z-Score.

Key Dynamics to Monitor

LICN profiles as a turnaround stock while RBA is a value play — different risk/reward profiles.

RBA carries more volatility with a beta of 0.53 — expect wider price swings.

RBA is growing revenue faster at 11.1% — sustainability is the question.

RBA generates stronger free cash flow (91M), providing more financial flexibility.

Bottom Line

RBA scores higher overall (68/100 vs 29/100) and 11.1% revenue growth. Both earn "Strong Buy" and "Avoid" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Lichen China Limited Class A Ordinary Shares

INDUSTRIALS · SPECIALTY BUSINESS SERVICES · USA

Lichen China Limited, an investment holding company, provides financial and taxation, education support, and software and maintenance services in the People's Republic of China. The company is headquartered in Jinjiang, China.

RB Global Inc.

INDUSTRIALS · SPECIALTY BUSINESS SERVICES · USA

Ritchie Bros. The company is headquartered in Burnaby, Canada.

Want to dig deeper into these stocks?